United States Patent (19) 11 Patent Number: 5,677,453 Cramm Et Al

Total Page:16

File Type:pdf, Size:1020Kb

United States Patent (19) 11 Patent Number: 5,677,453 Cramm Et Al US005677453A United States Patent (19) 11 Patent Number: 5,677,453 Cramm et al. 45 Date of Patent: Oct. 14, 1997 54 PROCESS FOR THE PREPARATION OF 46 R. Hull, A New Sythesis of 4:6-dihydroxypyrimidines-J. DCHLOROPYRIMDINES Chem. Soc. (1951) p. 2214. Contribution a la synthese de la dichloro-4-6 pyrimidine, 75 Inventors: Ginther Cramm; Wolker Kiss, both Hennart et al., Bull. de la Soc. Chim. France, (1959) pp. of Leverkusen; Guido Stefan, 741-742. Odenthal, all of Germany Experiments on the Synthesis of Purine Nucleosides. Part IV. Kenner et al., J. Chem. Soc. (1943), pp. 574-575. 73) Assignee: Bayer Aktiengesellschaft, Leverkusen, A New Synthesis of 4:6-Dihydroxpyrimidines, Hull, J. Germany Chem. Soc. (1951), p. 2214. Synthesis of 21 Appl. No.: 699,812 4-(p-Aminobenzenesulfonamido)-6-Methoxypyrimidine, 22 Filed: Aug. 19, 1996 Zasosov et al., Translated from Khimiko-Farmatsevticheskii Zhurnal, vol. 8, No. 12, pp. 28–31, Dec., 1974. Original 30 Foreign Application Priority Data article submitted Dec. 6, 1973. Aug. 25, 1995 DEl Germany ........................ 19531 299.6 Primary Examiner-John M. Ford Attorney, Agent, or Firm-Sprung Horn Kramer & Woods (51) Int. Cl. ... C07D 239/30 52 U.S. Cl. ..................... ... 544/334 57 ABSTRACT 58) Field of Search ............................................. 544/334 4,6-Dichloropyrimidines are obtained by the reaction of (56) References Cited 4,6-dihydroxypyrimidines with excess phosphoryl chloride in a particularly advantageous manner when no base is FOREIGN PATENT DOCUMENTS added, during and/or after the reaction 0.75 to 1.5 mol of O 251 246A1 1A1988 European Pat. Off.. phosphorus trichloride and 0.7 to 1.3 mol of chlorine are O 697 406A1 2/1996 European Pat. Off. added per equivalent of exchanged hydroxyl groups so that WO95/29166 11/1995 WIPO . an excess of phosphorus trichloride with respect to chlorine WO 96/23776 8/1996 WIPO . is always present, and finally phosphorus trichloride and phosphoryl chloride are separated off. This process can be OTHER PUBLICATIONS carried out in a particularly simple manner and also con Hennartet al., Contributionala synthesis dela dichloro-4-6 tinuously. pyrimidine-Societe Chimique de France No. 140, (1959) pp. 741-742. 10 Claims, No Drawings 5,677,453 1. 2 PROCESS FOR THE PREPARATION OF 46. admixed with phosphorus trichloride and the amount of DCHLOROPYRIMDINES chlorine given above so that always an excess of phosphorus trichloride with respect to chlorine is present in the reaction The present invention relates to an improved process for the preparation of 4,6-dichloropyrimidines from 4,6- mixture. The excess is preferably determined so that from dihydroxypyrimidines. 0.3 to 5% by weight, preferably from 1 to 3% by weight of 4,6-Dichloropyrimidines are intermediates, for example free phosphorus trichloride is always present. It is possible in the preparation of plant protection agents and dyes. to proceed so that phosphorus trichloride and chlorine are In known processes for the preparation of 4.6- metered in at a uniform rate, with a brief prior addition of dichloropyrimidines, 4,6-dihydroxypyrimidines are phosphorus trichloride. admixed with phosphoryl chloride and a base such as 10 Per equivalent of exchanged hydroxyl groups, for dimethylaniline or pyridine (see J. Chem. Soc. 1943,574; J. example from 0.75 to 1.5 mol of phosphorus trichloride can Chem. Soc. 1951, 2214Bull. Soc. Chim. France 1959, 741 be added, taking care that an excess thereof with respect to and Khim.-Pharm. Zhurnal 8(12), 28 (1974)-English trans chlorine is always present. lation p. 741). The addition of phosphorus trichloride and chlorine can For the work-up, the excess phosphoryl chloride is first 15 be carried out, for example, at from 60° to 110° C. Tem drawn off and the residue is either added to ice and the peratures of from 80° to 100° C. are preferred. When the product obtained by extraction and distillation or is sub addition of phosphorus trichloride and chlorine is complete, jected to a sublimation process by which the product is it can be advantageous, especially in batchwise operation, to obtained as sublimate. In this process, it is disadvantageous after-stir the mixture at from 60° to 110° C. for some time, that the bases are used in large quantities, but can only be 20 for example for 10 minutes to 3 hours. recovered and reused at considerable cost. Finally, an aque After completion of the reaction with phosphorustrichlo ous work-up is very costly because of the disposal of the ride and chlorine, the reaction mixture can be worked up, for waste water formed and the handling of extractants. A example by distillation. work-up by sublimation is also very costly on the industrial Because of the dilution effect of the phosphoryl chloride scale, for example with respect to the apparatus to be used 25 presentin the batch, it can be advantageous to use only apart and the occupational hygiene conditions for removal of the of the reaction mixture for the work-up, and to admix the product from the Sublimer. remainder, if desired after addition of phosphoryl chloride, Some attempts to improve the known processes by the so that the proportion of this in the reaction mixture does not use of Smaller amounts of bases failed because the yield of fall below a predetermined value, with fresh 46 4,6-dichloropyrimidines is greatly reduced and the forma 30 dihydroxypyrimidine and, after complete reaction of the tion of high boilers and resins greatly increases (see latter, to react again with the corresponding amount of Example 5). phosphorus trichloride and chlorine. This procedure can be A process has now been found for the preparation of repeated as often as desired. 4,6-dichloropyrimidines by the reaction of 4.6- The addition of phosphorus trichloride can also be car dihydroxypyrimidines with excess phosphoryl chloride, 35 ried out before or simultaneously with the addition of the characterized in that no base is added, after the reaction from 4,6-dihydroxypyrimidine. It can thus be advantageous for 0.7 to 1.3 mol of chlorine is added per equivalent of practical operation to add the 4,6-dihydroxypyrimidines as a exchanged hydroxyl group in the presence of phosphorus suspension in phosphorus trichloride. In this case, the addi trichloride so that an excess of phosphorus trichloride with tion of phosphorustrichloride before the addition of chlorine respect to chlorine is always present, and finally the phos can be omitted. phorustrichloride and phosphoryl oxychloride are separated It has been found to be particularly favourable to carry off. out this reaction sequence and the subsequent distillation In the process of the invention, for example 46 separation continuously. dihydroxypyrimidine or 4,6-dihydroxypyrimidines substi The removal of phosphoryl trichloride and phosphoryl tuted in position 2 and/or position 5 with, for example, 45 chloride can, according to whether the process of the inven C-Co-alkyl and/or C-Co-aryl groups can be used. The tion is carried out batchwise, semicontinuously, or alkyl and aryl groups can in turn if desired contain, for continuously, be carried out in various ways. example, halogen, nitro and/or C-C-alkoxy as substitu In batchwise operation, for example, the whole of the ents. Independently of a substitution in position 2, reaction mixture can be subjected to a distillation, preferably 5-halogen-, for example, 5-chlorine-substituted 4,6- 50 at reduced pressure, and the phosphorus trichloride and dihydroxypyrimidines can be used. Preferably, 4,6- phosphorus oxychloride can be separated off in succession. dihydroxypyrimidine is used. Where 4, 6 In semicontinuous operation, the procedure can be, for dihydroxypyrimidines or 4,6-dihydroxypyrimidines are example, first adding to a completely reacted reaction mix referred to below, the substituted types shall be regarded as ture more 4,6-dihydroxypyrimidine followed by phosphorus included. 55 trichloride and chlorine in the manner described above, in For each mole of 4,6-dihydroxypyrimidine used, for the amounts described above, and at the temperatures example 2.5 to 12 mol of phosphoryl chloride can be used. described above, and allowing the reaction to proceed. This This amount is preferably from 3.5 to 5 mol. further addition can, depending on the size of the reaction For the reaction of 4,6-dihydroxypyrimidines with phos vessel used, be repeated a number of times, for example up phoryl chloride, temperatures for example in the range 60° to 20 times. Part of the reaction mixture so produced can to 110° C. are suitable. Temperatures from 80 to 100° C. are then be removed, preferably over arange of 20% by weight preferred. It is possible to proceed so that, for example, the of the amount of the increase in weight since the first phosphoryl chloride is added first and the 46 addition of 4,6-dihydroxypyrimidine, Phosphoryl chloride, dihydroxypyrimidine is metered into it. Other working then 4,6-dihydroxypyrimidine, and then phosphorustrichlo methods are also possible. 65 ride and chlorine can then be added again to the residue as Preferably after the 4,6-dihydroxypyrimidine used has described above, and, after the reaction has subsided, a part dissolved in the phosphoryl chloride, the reaction mixture is of the reaction mixture can be removed, preferably with a 5,677,453 3 4 range of from +20% by weight of the amount that corre EXAMPLES sponds to the increase in weight since the addition of 4,6-dihydroxypyrimidine. This cycle can be repeated as Example 1 often as desired, for example up to 50 times. a) Starting phase: The portions of the reaction mixture separated off in this To 2500 g of phosphoryl chloride, 28 g of 4,6- procedure can be subjected, for example, to a distillation, dihydroxypyrimidine (referred to below as DHP) were preferably under reduced pressure, and the phosphorus added at from 85° to 90° C.
Recommended publications
  • Preparation of Aromatic Carbonyl Compounds
    ~" ' MM II II II Ml I III II II I Ml II I II J European Patent Office © Publication number: 0 178 184 B1 Office_„. europeen- desj brevets^ » © EUROPEAN PATENT SPECIFICATION © Date of publication of patent specification: 28.04.93 © Int. CI.5: C07C 45/45, C07C 49/76, C07C 51/58 © Application number: 85307320.3 @ Date of filing: 11.10.85 © Preparation of aromatic carbonyl compounds. © Priority: 11.10.84 US 659598 (73) Proprietor: RAYCHEM CORPORATION (a Dela- ware corporation) @ Date of publication of application: 300 Constitution Drive 16.04.86 Bulletin 86/16 Menlo Park, California 94025(US) © Publication of the grant of the patent: @ Inventor: Horner, Patrick James 28.04.93 Bulletin 93/17 139 Buckthorn Way Menlo Park California 94025(US) © Designated Contracting States: Inventor: Jansons, Vlktors AT BE CH DE FR GB IT LI NL SE 123 New York Avenue Los Gatos California 95030(US) References cited: Inventor: Gors, Helnrlch Carl EP-A- 0 024 286 EP-A- 0 069 598 2508 Mardell Way DE-A- 2 014 514 GB-A- 1 420 506 Mountain View California, 94043(US) GB-A- 2 103 604 US-A- 1 874 580 US-A- 3 282 989 Representative: Jay, Anthony William et al Raychem Limited Intellectual Property Law Department Faraday Road Dorcan Swindon Wiltshire (GB) 00 00 00 Note: Within nine months from the publication of the mention of the grant of the European patent, any person ® may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition CL shall be filed in a written reasoned statement.
    [Show full text]
  • 5 Phosphorus Oxychloride1 Acute Exposure Guideline Levels
    Acute Exposure Guideline Levels for Selected Airborne Chemicals: Volume 10 Committee on Acute Exposure Guideline Levels Committee on Toxicology Board on Environmental Studies and Toxicology Division on Earth and Life Studies Copyright © National Academy of Sciences. All rights reserved. Acute Exposure Guideline Levels for Selected Airborne Chemicals: Volume 10 THE NATIONAL ACADEMIES PRESS 500 FIFTH STREET, NW WASHINGTON, DC 20001 NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Insti- tute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance. This project was supported by Contract No. W81K04-06-D-0023 and EP-W-09-007 be- tween the National Academy of Sciences and the U.S. Department of Defense and the U.S. Environmental Protection Agency. Any opinions, findings, conclusions, or recom- mendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for this project. International Standard Book Number-13: 978-0-309-21987-7 International Standard Book Number-10: 0-309-21987-6 Additional copies of this report are available from The National Academies Press 500 Fifth Street, NW Box 285 Washington, DC 20055 800-624-6242 202-334-3313 (in the Washington metropolitan area) http://www.nap.edu Copyright 2011 by the National Academy of Sciences.
    [Show full text]
  • Psilocybin † † † ‡ Haden A
    Review pubs.acs.org/chemneuro DARK Classics in Chemical Neuroscience: Psilocybin † † † ‡ Haden A. Geiger, Madeline G. Wurst, and R. Nathan Daniels*, , † Department of Pharmaceutical Sciences, Lipscomb University College of Pharmacy and Health Sciences, Nashville, Tennessee 37204, United States ‡ Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6600, United States ABSTRACT: Psilocybin is found in a family of mushrooms commonly known as “magic mushrooms” that have been used throughout history to induce hallucinations. In the late 1950s Albert Hofmann, of Sandoz Laboratories, identified and synthesized the psychoactive compounds psilocybin and psilocin which are found in psilocybe mushrooms. Psilocybin was marketed by Sandoz as Indocybin for basic psychopharmacological and therapeutic clinical research. Psilocybin saw a rapid rise in popularity during the 1960s and was classed as a Schedule I drug in 1970. This led to a significant decrease in psilocybin research. Recently, however, preliminary studies with psilocybin have shown promise as potential for the treatment of obsessive compulsive disorder, alcohol addiction, tobacco addiction, and major depressive disorder, and the treatment of depression in terminally ill cancer patients. This review describes in detail the synthesis, metabolism, pharmacology, adverse drug reactions, and importance of psilocybin to neuroscience in the past and present. KEYWORDS: Psilocybin, psilocin, indolealkylamine, hallucinogen, psychedelic, magic mushrooms, mushrooms, O-acetylpsilocin, indocybin I. INTRODUCTION The structure of psilocybin, and other indolealkylamine Psilocybin (1, Figure 1), a tryptamine alkaloid, is found in a hallucinogens, is similar to that of the endogenous neuro- family of mushroom-forming fungi that when ingested can transmitter serotonin (3), the hormone melatonin (4), and the hypothesized endogenous psychedelic, N,N-dimethyltrypt- cause hallucinations.
    [Show full text]
  • Solvent-Free and Safe Process for the Quantitative Production of Phosgene from Triphosgene by Deactivated Imino-Based Catalysts
    Organic Process Research & Development 2010, 14, 1501–1505 Solvent-Free and Safe Process for the Quantitative Production of Phosgene from Triphosgene by Deactivated Imino-Based Catalysts Heiner Eckert* and Johann Auerweck Department of Chemistry, Technische UniVersitaet Muenchen, Lichtenbergstr. 4, Garching 85747, Germany Abstract: Scheme 1. Decomposition of triphosgene (1a) into carbon tetrachloride, carbon dioxide, and 1 equiv of phosgene (3) Phosgene is quantitatively formed from solid triphosgene in a solvent-free and safe process without any reaction heat, catalyzed by planar N-heterocycles with deactivated imino functions. The rate of phosgene generation is adjustable to the rate of phosgene consumption in the subsequent phosgenation reaction by thermal control, catalyst concentration, and in some cases, specific proper- ties of selected metal phthalocyanines. A thermal runaway reaction of this process is impossible. phosgene in most reactions, yet several phosgenation reactions are advantageously carried out with phosgene, that is, when excessive triphosgene is difficult to remove during the reaction Introduction workup because of its high boiling point of over 200 °C. Its Phosgene (3) is a highly useful and versatile chemical in excess can be destroyed by hydrolysis, when phosgenation performing syntheses.1a Although consisting of only four atoms, products are not sensitive to moisture as are carbonates, four important transformations can be carried out with it in carbamates, ureas, diarylketones, alkylhalides, cyanides, and organic
    [Show full text]
  • Phosphonate–Phosphonochloridate Conversion Bogdan Iorga, Duncan Carmichael, Philippe Savignac
    Phosphonate–phosphonochloridate conversion Bogdan Iorga, Duncan Carmichael, Philippe Savignac To cite this version: Bogdan Iorga, Duncan Carmichael, Philippe Savignac. Phosphonate–phosphonochloridate conversion. Comptes rendus de l’Académie des sciences. Série IIc, Chimie, Elsevier, 2000, 3 (11-12), pp.821-829. 10.1016/s1387-1609(00)01207-x. hal-03161486 HAL Id: hal-03161486 https://hal.archives-ouvertes.fr/hal-03161486 Submitted on 10 Mar 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Phosphonate-Phosphonochloridate Conversion Bogdan Iorga, Duncan Carmichael, Philippe Savignac Laboratoire Hétéroéléments et Coordination, UMR CNRS 7653, DCPH, Ecole Polytechnique, 91128 Palaiseau Cedex, France; E-mail : [email protected] __________________________________________________________________________________________ Abstract - This review deals with the phosphonate-phosphonochloridate conversion. The different phosphorus-chlorine bond forming reagents (COCl2, (COCl)2, SOCl2, PCl5, POCl3, Ph3PCl2, trichloro(o-phenylenedioxy)phosphorane)
    [Show full text]
  • Searching for New Biologically Active Compounds Derived from Isoquinoline Alkaloids †
    Proceeding Paper Searching for New Biologically Active Compounds Derived from Isoquinoline Alkaloids † Anna Kmieciak 1, Marta Ćwiklińska 1, Karolina Jeżak 1, Afef Shili 2 and Marek P. Krzemiński 1,* 1 Faculty of Chemistry, Nicolaus Copernicus University, 87-100 Toruń, Poland; [email protected] (A.K.); [email protected] (M.Ć.); [email protected] (K.J.) 2 Chemistry Department, Faculty of Sciences of Sfax, University of Sfax, Sfax 3029, Tunisia; [email protected] * Correspondence: [email protected] † Presented at the 24th International Electronic Conference on Synthetic Organic Chemistry, 15 November–15 December 2020; Available online: https://ecsoc-24.sciforum.net/. Abstract: Many isoquinoline alkaloids are biologically active compounds and successfully used as pharmaceuticals. Compounds belonging to the isoquinolines and tetrahydroisoquinolines (TIQs) can be used as anesthetics, antihypertensive drugs, antiviral agents, and vasodilators. In the presented studies, the search for new compounds and synthesis of tetrahydroisoquinoline alkaloid derivatives was undertaken. Several dihydroisoquinolines were synthesized by Bishler–Napieralski reaction from the corresponding amides. Dihydroisoquinolines were reduced with sodium borohydride to obtain racemic tetrahydroisoquinolines. Asymmetric reduction of selected 3,4-dihydroisoquinolines was attempted with borane in the presence of chiral terpene spiroboranes. Keywords: isoquinoline; alkaloids; biologically active compound Citation: Kmieciak, A.; Ćwiklińska, M.; Jeżak, K.; Shili, A.; Krzemiński, M.P. Searching for New Biologically 1. Introduction Active Compounds Derived from Isoquinoline Alkaloids. Chem. Proc. Isoquinoline and its derivatives are used as starting materials in the synthesis of 2021, 3, 97. https://doi.org/10.3390/ dyes, insecticides, and pharmaceuticals. Tetrahydroisoquinoline (TIQ) is one of many ecsoc-24-08417 representatives of N-heterocyclic compounds.
    [Show full text]
  • Searching for New Biologically Active Compounds Derived from Isoquinoline Alkaloids †
    Proceedings Searching for New Biologically Active Compounds Derived from Isoquinoline Alkaloids † Anna Kmieciak 1, Marta Ćwiklińska 1, Karolina Jeżak 1, Afef Shili 2 and Marek P. Krzemiński 1 1 Faculty of Chemistry, Nicolaus Copernicus University, Toruń, Poland 2 Chemistry Department, Faculty of Sciences of Sfax, University of Sfax, Tunisia † Presented at the 24th International Electronic Conference on Synthetic Organic Chemistry, 15 November– 15 December 2020; Available online: https://ecsoc-24.sciforum.net/. Received: date; Accepted: date; Published: date Abstract: Many isoquinoline alkaloids are biologically active compounds and are successfully used as pharmaceuticals. Compounds belonging to isoquinolines and tetrahydroisoquinolines (TIQs) can be used as anesthetics, antihypertensive drugs, antiviral agents, and vasodilators. In the presented studies, the search for new compounds and synthesis of tetrahydroisoquinoline alkaloid derivatives was undertaken. Several dihydroisoquinolines were synthesized by Bishler-Napieralski reaction from the corresponding amides. Dihydroisoquinolines were reduced with sodium borohydride to obtain racemic tetrahydroisoquinolines. Asymmetric reduction of selected 3,4-dihydroisoquinolines was attempted with borane in the presence of chiral terpene spiroboranes. Keywords: isoquinoline; alkaloids; biologically active compound 1. Introduction Isoquinoline and its derivatives are used as starting materials in the synthesis of dyes, insecticides, and pharmaceuticals. Tetrahydroisoquinoline (TIQ) is one of
    [Show full text]
  • Phosphoryl Trichloride Cas N°: 10025-87-3
    OECD SIDS PHOSPHORYL TRICHLORIDE FOREWORD INTRODUCTION PHOSPHORYL TRICHLORIDE CAS N°: 10025-87-3 UNEP PUBLICATIONS 1 OECD SIDS PHOSPHORYL TRICHLORIDE SIDS Initial Assessment Report For SIAM 19 Berlin, Germany, 19-22 October 2004) 1. Chemical Name: Phosphoryl trichloride 2. CAS Number: 10025-87-3 3. Sponsor Country: Germany Contact Point: BMU (Bundesministerium für Umwelt, Naturschutz und Reaktorsicherheit) Contact person: Prof. Dr. Ulrich Schlottmann Postfach 12 06 29 D- 53048 Bonn 4. Shared Partnership with: 5. Roles/Responsibilities of the Partners: Name of industry sponsor Bayer AG, Germany /consortium Contact person: Dr. Burkhardt Stock D-51368 Leverkusen Gebäude 9115 Process used The BUA Peer Review Process : see next page 6. Sponsorship History How was the chemical or by ICCA-Initiative category brought into the OECD HPV Chemicals Programme ? 7. Review Process Prior to last literature search (update): the SIAM: 14 March 2004 (Human Health): databases medline, toxline; search profile CAS-No. and special search terms 9 March 2004 (Ecotoxicology): databases CA, biosis; search profile CAS-No. and special search termsOECD/ICCA 8. Quality check process: As basis for the SIDS-Dossier the IUCLID was used. All data have been checked and validated by BUA. A final evaluation of the human health part has been performed by the Federal Institute for Risk Assessment (BfR) and of the ecotoxicological part by the Federal Environment Agency (UBA). 2 UNEP PUBLICATIONS OECD SIDS PHOSPHORYL TRICHLORIDE 9. Date of Submission: Deadline for circulation: 23 July 2004 10. Date of last Update: Last literature search: IUCLID Chapters 1-4: Chapter 5: 2003-05-01 11. Comments: OECD/ICCA - The BUA* Peer Review Process Qualified BUA personnel (toxicologists, ecotoxicologists) perform a quality control on the full SIDS dossier submitted by industry.
    [Show full text]
  • Template for Writing Articles for Thieme Chemistry Journals
    1 SYNLETT: LETTER Organocatalytic phosphorylation of alcohols using pyridine-N-oxide James I. Murray,a Rudiger Woscholskia,b and Alan C. Spiveya* aDepartment of Chemistry, South Kensington Campus, Imperial College London, SW7 2AZ, United Kingdom bInstitute of Chemical Biology, Imperial College London, London SW7 2AZ, United Kingdom Fax: +44 (0)20 759 45841 E-mail: [email protected] Received: The date will be inserted once the manuscript is accepted. Abstract: Phosphorylation of alcohols by phosphoryl chlorides catalyzed by pyridine-N-oxide is reported. The utility of this method is demonstrated through phosphorylation of primary, secondary and a tertiary alcohol as well as phenols under mild reaction conditions and with low catalyst loading (5 mol%). Key words: Phosphorylation, alcohols, pyridine-N-oxide, organocatalysis. O Exisiting methods O O O Phosphorylation of alcohol groups in e.g. peptides, Exisiting methods O Lewis acids: P P Cl OR O N OR Cl proteins, inositols, glycerols and steroids plays a t OR OR 1) Ti(O Bu)4 (5-20 mol%) + A or C 4 or Ph or A Ph B pivotal role in many physiologically important 2) TiCl mol%) + A 2) TiCl4 (2(2 mol%) + O Jones et al. (refs 9-13; R = Ph, Et) 1 or processes. Disease states including cancers and 1 3) Cu(OTf) 2 (20 mol%) + B 1 P OR R OH 2 R1O O O OR 1 ° ° ° Et N or i-Pr NEt P P OBn immune system disorders are often characterized by R = 1°,2°,3° Et3N or i-Pr2NEt R = Ph, Bn, Et BnO O OBn C CH Cl BnO 2,3 & phenolic CH2Cl2 BnO OBn perturbation of these processes.
    [Show full text]
  • United States Patent Office Faterated (Oct
    3,153,081 United States Patent Office Faterated (Oct. 13, 1964 2 3,153,081 Substitution-i.e., monophosphorylation-has been ac PROCESS FOR PREPARNG PHENYL complished to a very great extent as will be seen from PHOSPHORODCHLOREDATES the ensuing description. - Francis X. Markley, Botand Brook, N.J., and Calvin . Another feature of this invention is that the catalysts Worrel, Detroit, Mich., assignors to Ethyl Corporation, are highly specific. For example, whereas m-cresol and New York, N.Y., a corporation of Virginia phosphoryl chloride must be heated above 200° C. for 5 No Drawing. Filed Oct. 26, 1962, Ser. No. 233,435 to 6 hours to obtain m-tolyl phosphorodichloridate, the 7 Claims. (Ci. 260-461) presence in the same reaction mixture of as little as one This invention relates to, and has as its principal object, mole percent of aluminum chloride, based on the phenol, the preparation of phenyl phosphorodichloridates. O made it possible to complete the reaction in 40 to 50 min This application is a continuation-in-part of S.N. utes at 105 C. In sharp contrast to this, magnesium and 730,265, filed April 23, 1958, now abandoned. zinc dust, magnesium and zinc chlorides, phosphorus tri Phenyl phosphorodichloridates are very useful chemi chloride and the highly-acidic protonated acids-trichloro cal intermediates in the synthesis of phenyl dimethyl phos acetic and p-toluene sulfonic acids-have been investi phates. Many of the latter compounds are exceptionally 15 gated as possible catalysts in this reaction. Of these, effective ignition control compounds when blended in only magnesium chloride and phosphorus trichloride gave small quantity with leaded gasoline.
    [Show full text]
  • United Nations
    UN/SCETDG/46/INF.33 UN/SCEGHS/28/INF.18 Committee of Experts on the Transport of Dangerous Goods and on the Globally Harmonized System of Classification and Labelling of Chemicals 24 November 2014 Sub-Committee of Experts on the Sub-Committee of Experts on the Globally Harmonized Transport of Dangerous Goods System of Classification and Labelling of Chemicals Forty-sixth session Twenty-eight session Geneva, 1– 9 December 2014 Geneva, 10 – 12 (morning) December 2014 Item 8 (c) of the provisional agenda Item 2 (b) (i) of the provisional agenda Classification criteria and related hazard Issues relating to the Globally Harmonized System communication: work of the Sub-Committee of Experts of Classification and Labelling of Chemicals: on the Transport of Dangerous Goods (TDG): physical criteria for water reactivity hazards Criteria for water-reactivity, agenda item 8(c) HM-14 project status report Transmitted by the expert from the United States of America Introduction 1. During previous sessions, the Sub-Committee has been presented with information related to the development of criteria and test methods for the classification of materials that in contact with water evolve toxic and/or flammable gases (see INF.40 of the 42nd session and ST/SG/AC.10/C.3/2013/21) through a contract managed by the U.S. Transportation Research Board (TRB). This work is now complete and the full report titled: HM-14: Test Procedures and Classification Criteria for Release of Toxic Gases from Water-Reactive Materials published on 8 October, 2014. The report is available online: http://onlinepubs.trb.org/onlinepubs/hmcrp/hmcrp_rpt_013.pdf 2.
    [Show full text]
  • Synthesfs of SOME ISOQUINOLINE DERIVATIVES*
    Tcftahdron, 1959, Vol. 7, pp. 118 to 122. Pcrgamon Prwa Ltd. P&ted in Northern Wand SYNTHESfS OF SOME ISOQUINOLINE DERIVATIVES* RYUJI TACHIKAWA Faculty of Pharmaceutical Sciences, University of Tokyo (Received 3 November 1958 ; in revised form 1 April 1959) Abstmct-The Bischler-Napieralski reaction has been applied to the synthesis of several isoquinolinc derivatives related to papaverine but devoid of one or two methoxyl groups in positions 6 and 7. THE isoquinoline derivatives Ia, b, c, d related to papaverine have been synthesized’ with the object of subsequently investigating their physiological proplerties and to determine the influence of methoxyl groups in positions 6 and/or 7. I R2 Ia,b,c, d ; !=_$;H,R,=OCH,,n= I = CH,, RI--R, = 0-CH,--O, n = f c: R = H: R: = CHs, R,--R, I= 0-CH,-0, n = 0 d: R = OCH,, R, = H, R, = OCH,, n = I fawas synthesized by condensing /?-cylcohexa-1,4-dienylethylamine with 3,4-dimethoxy- phenylacetyl chloride giving Ha which was cychzed forming the unstable intermediate HIa. The latter on dehydrogenation gave IVa which was also obtained by cyclizing N-(3’,4’dimethoxyphenylacetyl)-~-phenylethylamine. Further dehydrogenation of IVa by palladium in boiling ethyl cinnamate gave I-(3’,4’-dimethoxybenzyl)-iso- quinoline Ia. The structure of Ia is supported by the results of analyses and U.V. spectrum giving by Nolier et aL2 for papaverine. Ib and Ic were synthesized by condensing 3-(cyclohexa- 1’,4’-dienyl)-1 ‘-(Z-amino- propane) VII with 3,4-methyIenedioxyphenylacety1 and 3,4-methylenedioxybenzoyl chlorides respectively, the products in each case being cyclized and dehydrogenated giving Ib and lc.
    [Show full text]